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A B S T R A C T
Riboswitches are RNA elements found in non-coding regions of messenger RNAs that regulate gene expression
through a ligand-triggered conformational change. Riboswitches typically bind tightly and specifically to their
ligands, so they have the potential to serve as highly effective sensors in vitro. In B. subtilis and other gram-
positive bacteria, purine nucleotide synthesis is regulated by riboswitches that bind to guanine. We modified the
xpt-pbuX guanine riboswitch for use in a fluorescence quenching assay that allowed us to specifically detect and
quantify guanine in vitro. Using this assay, we reproducibly detected as little as 5 nM guanine. We then produced
sensors for 2′-deoxyguanosine and cyclic diguanylate (c-diGMP) by appending the P1 stem of the guanine ri-
boswitch to the ligand-binding domains of a 2′-deoxyguanosine riboswitch and a c-diGMP riboswitch. These
hybrid sensors could detect 15 nM 2′-deoxyguanosine and 3 nM c-diGMP, respectively. Each sensor retained the
ligand specificity of its corresponding natural riboswitch. In order to extend the utility of our approach, we
developed a strategy for the in vitro selection of sensors with novel ligand specificity. Here we report a proof-of-
principle experiment that demonstrated the feasibility of our selection strategy.
1. Introduction
Riboswitches are regulatory elements, found in the non-coding re-
gions of messenger RNAs, that control gene expression through the
direct sensing of signaling molecules (Serganov and Nudler, 2013).
Binding of a specific ligand to a riboswitch stabilizes one of two alter-
native conformations resulting in either an increase (“ON” switch) or
decrease (“OFF” switch) in the level of gene expression. Riboswitches
can control transcription, translation, splicing, or RNA stability. To
date, riboswitches have been discovered that respond to ions, purines
and purine derivatives, enzyme cofactors, and amino acids. Since the
discovery of riboswitches, there has been an explosion of interest in
exploiting their high affinity and specificity for their ligands to develop
biosensors for monitoring the concentration of compounds in living
cells or in solution (Fowler et al., 2010; Fowler et al., 2013; You et al.,
2015; Su et al., 2016). There is also great interest in using riboswitches
as novel gene regulatory modules in synthetic biology (Topp and
Gallivan, 2010; Chappell et al., 2013; Groher and Suess, 2014; Etzel and
Morl, 2017; Hallberg et al., 2017).
Riboswitches are modular. They consist of a ligand-binding domain
(“aptamer domain”) and an “expression platform” that changes con-
formation in response to ligand binding. Sometimes, domains from two
different riboswitches can be swapped to generate new synthetic ri-
boswitches (Ceres et al., 2013aa,b; Litke et al., 2016; Rossmanith and
Narberhaus, 2016). In addition, aptamers produced by in vitro selection
have been successfully coupled to expression platforms to produce ar-
tificial riboswitches (also called “signaling aptamers”) or to ribozymes
to produce ligand-regulated allosteric “aptazymes” (Soukup and
Breaker, 1999; Robertson and Ellington, 2000; Sharma et al., 2008).
These constructs have been used to monitor ligand concentration in vivo
and in vitro or to regulate gene expression in response to novel ligands.
We would like to produce new riboswitches with altered ligand
specificity for use as biosensors. Producing highly effective biosensors
through rational design is a challenging problem. Two examples from
the literature are particularly relevant to our work. The purpose of
these two experiments was not to produce effective sensors but to re-
veal the key elements that determine ligand specificity. Nonetheless,
they illustrate the difficulty of using a rational design approach to
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engineer biosensors with novel ligand specificity. C74 in the aptamer
domain of the guanine riboswitch forms a Watson-Crick base pair with
the guanine ligand (Serganov et al., 2004). When Gilbert et al. changed
this C to U, the ligand preference changed from guanine to adenine but
the mutant aptamer domain bound to adenine poorly compared to
naturally-occurring adenine riboswitches (Gilbert et al., 2006). Adenine
riboswitches have a U at position 74, but their sequences differ from
that of the guanine riboswitch at many additional sites (Serganov et al.,
2004). All of these differences are required to make them effective
adenine sensors. Edwards and Batey gradually replaced sequences in
the aptamer domain of the xpt-pbuX guanine riboswitch with the cor-
responding sequences from a 2′-deoxyguanosine riboswitch (Edwards
and Batey, 2009). Only after extensive substitutions was a hybrid ap-
tamer domain produced that could bind to 2′-deoxyguanosine with an
affinity and specificity similar to the natural 2′-deoxyguanosine ri-
boswitch.
Given the difficulties associated with rational design, it would be
very useful to have a simple in vitro selection strategy for isolating ri-
boswitches with novel ligand specificity. Traditional aptamers pro-
duced by in vitro selection are selected only for their ability to bind to a
specific ligand. Thus, to produce an effective sensor by coupling a se-
lected aptamer to an expression platform or to a ribozyme often re-
quires extensive re-engineering and optimization (Ceres et al.,
2013aa,b; Soukup and Breaker, 1999; Robertson and Ellington, 2000).
We and others have reported in vitro selection systems that directly
select “signaling” aptamers that not only bind to a ligand but also signal
the presence of the ligand by undergoing a specific conformational
change (Nutiu and Li, 2005; Morse, 2007; Rajendran and Ellington,
2008; Vandenengel and Morse, 2009). Here we exploited the modular
nature of naturally-occurring riboswitches to produce highly sensitive
and specific sensors. We then used our sensor design and our previous
approach for producing signaling aptamers as the bases for a selection
strategy with the potential to directly select signaling aptamers with
novel ligand specificity. We report a proof-of-principle experiment de-
monstrating the feasibility of our selection strategy.
2. Materials and methods
2.1. Fluorescence measurements
All measurements of fluorescence intensity were performed with a
Modulus fluorometer (Turner Biosystems) in raw fluorescence mode
using the blue fluorescence optical kit. Measurements were reported in
“fluorescence standard units (FSU)”.
2.2. Oligonucleotides
Oligonucleotides were obtained from Integrated DNA Technologies,
Inc. (IDT).
DM024 (GGTATAATAGGAACACTCATataatCGCGTGGATATGGCAC
GCAagtttctaccGGGCACCGTAAATGTCCgactATGGGTGAGCAATGGA).
Encodes nucleotides 1–91 of the xpt-pbuX guanine riboswitch from
Bacillus subtilis (Mandal et al., 2003). The first 2 nucleotides were
changed from A to G for efficient transcription initiation by T7 RNA
polymerase. The resulting RNA was called xpt RNA (1–91). For in vitro
selection, the lower case bases were partially randomized.
JL001 (GGTATAATAGGAACACTCATAcagggtagcataatgggctactgaccc
cgccttcaaacctatttggagacTATGGGTGAGCAATGGA). Encodes deoxyguanosine-
guanine hybrid riboswitch. Upper case bases are from DM024. Lower case
bases are from the 2′-deoxyguanosine riboswitch found in the ribonucleotide
reductase gene of Mesoplasma florum (Kim et al., 2007).
DM025 (GATAATACGACTCACTATAGGTATAATAGGAACACTCA). Upstream
primer for amplifying DM024 and JL001. Includes T7 promoter (bold)
for in vitro transcription with T7 RNA polymerase.
DM026 (TCCATTGCTCACCCA). Downstream primer for amplifying
DM024 and JL001 and for reverse transcription. This oligo was HPLC
purified to guarantee that the 5′ end the oligo (3′ end of transcript) was
intact.
JL002 (GGTATAATAGGAACACTCgcacagggcaaaccattcgaaagagtggga
cgcaaagcctccggcctaaaccagaagacatggtaggtagcggggttaccGGGTGAGCAAT
GGA). Encodes c-diGMP-guanine hybrid riboswitch. Upper case bases
are from the DM024. Lower case bases are from a c-diGMP riboswitch
found in Vibrio cholera (Vc2) (Sudarsan et al., 2008). We removed one
nucleotide from each of the priming sites so we used two new primers
for PCR (DM025S and DM026S below).
DM025S (GATAATACGACTCACTATAGGTATAATAGGAACACTC). Upstream
primer for amplifying JL002. It is identical to DM025 but is one nu-
cleotide shorter.
DM026S (TCCATTGCTCACCC). Downstream primer for amplifying
JL002. It is identical to DM026 but is one nucleotide shorter. This oligo
was HPLC purified.
5′T-1(AGCATTGCTTGCTC). Corresponds to the sequence of the 5′
half of the terminator from the xpt-pbuX guanine riboswitch (Serganov
et al., 2004).
3′T-1 (GAGCGGGCAATGCT). Corresponds to the sequence of the 3′
half of the terminator from the xpt-pbuX guanine riboswitch (Serganov
et al., 2004).
5′T-7 labeled with quencher (5IAbFQ-CATTGCTCACCC). Variant of
5′T-1 chosen for use in fluorescence quenching assay. 5IAbFQ is the
Iowa Black fluorescence quencher attached to the 5′ end.
5′T-7 labeled with biotin (5BiotinTEG-CATTGCTCACCC). Biotin is
attached to the 5′ end of 5′T-7 via a 16 atom linker.
3′T-3 (GAGTGAGCAATG). Variant of 3′T-1 chosen for use in the
fluorescence quenching assay.
Sequences of other oligonucleotides tested for use in the fluores-
cence quenching assay are given in Fig. 3.
2.3. Synthesis, labeling, purification, and quantification of RNA
Transcription templates were prepared by amplifying DM024,
JL001, or JL002. Primers for amplifying DM024 and JL001 were
DM025 and DM026. Primers for amplifying JL002 were DM025S and
DM026S. Reaction contained: 5 μL (5 ng) oligonucleotide; 12 μL
(240 pmol) of each primer; and 200 μL PCR supermix (Invitrogen).
Reactions were divided into 4 equal aliquots and PCR was performed
for 25 cycles. Each cycle consisted of 94 °C for 30 s, 45 °C for 30 s, and
72 °C for 30 s. PCR products were pooled, diluted to 400 μL with water,
extracted once with phenol:chloroform:isoamyl alcohol (25:24:1 v/v),
ethanol precipitated, and dissolved in 30 μL water. The upstream PCR
primers (DM025 and DM025S) included a T7 RNA polymerase pro-
moter at their 5′ ends allowing the PCR products to be used as templates
for in vitro transcription. In vitro transcription was performed with the
TranscriptAid T7 High Yield Transcription Kit (Thermo Scientific).
Reactions contained: 30 μL (∼600 ng) PCR product; 85 μL water; 64 μL
5× buffer; 116 μL 25mM NTPs; 25 μL enzyme soln. Reactions were
split into 2 equal aliquots and incubated for 6 h at 40 °C. 2 μL of 1 U/μL
DNase was added to each tube and incubation was continued for an-
other 15min. After incubation, precipitates formed (likely pyropho-
sphate). The precipitates were pelleted by spinning for 3min at top
speed in a microcentrifuge, and the supernatants were transferred
to new tubes. The samples were extracted twice with phenol:-
chloroform:isoamyl alcohol (25:24:1 v/v). Each reaction was split into
4 equal aliquots. Each aliquot was diluted to 400 μL with water and the
RNA was precipitated. Each pellet was dissolved in 100 μL of water and
two aliquots of 50 μL were each passed through a chromaspin-10 gel
filtration spin column (Clontech). Each aliquot was diluted to 400 μL
with water and precipitated and the pellets were dissolved in 100 μL of
water. The aliquots were combined and the concentration of the RNA
was determined by absorbance at 260 nm. Each RNA was labeled by
oxidizing the 3′ ends with sodium periodate (Sigma) and reacting the
oxidized RNA with fluorescein-5-thiosemicarbazide (Sigma). Oxidation
reactions contained: 144 μL (150 μg) RNA; 18 μL 200mM NaCH3COO
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pH 5.5; and 18 μL 200mM NaIO4 (0.5 g/10mL; made fresh). The re-
actions were incubated for 1 h at room temperature in the dark. Excess
NaIO4 was consumed by adding 180 μL of 2% ethylene glycol and in-
cubating for 10min at room temperature in the dark. Each reaction was
diluted to 800 μL with water, divided into two aliquots of 400 μL and
the RNA was precipitated. The pellets were dissolved in 400 μL of water
and the RNA was precipitated again and each pellet was dissolved in
97.5 μL of water and combined. Labeling reactions contained 195 μL of
RNA from the oxidation reactions; 22.5 μL 1M NaCH3COO pH 5.5;
7.5 μL 100mM fluorescein-5-thiosemicarbazide dissolved in di-
methylformamide (Sigma). Reactions were incubated for 1 h at room
temperature in the dark. The reactions were diluted to 400 μL with
water and precipitated. Both labeled and unlabeled RNAs were purified
from an 8% polyacrylamide gel by electroelution using D-tube dialysis
tubes (Novagen). Electroeluted RNAs were precipitated and dissolved
in 100 μL water. The concentration of each RNA was determined by
absorbance at 260 nm. An aliquot of each labeled and gel-purified RNA
was diluted 200-fold and the fluorescence intensity was measured.
Fluorescence intensity was typically about 1.5×105 FSU per pmol of
RNA.
2.4. Electrophoretic mobility shift assays (EMSA)
To identify DNA oligonucleotides that could efficiently form a stable
duplex with xpt RNA (1–91), we purchased 9 oligonucleotides (5′T-2
through 5′T-10) predicted to have a range of melting temperatures (Tm)
when annealed to xpt RNA (1–91). 10 μL annealing reactions contained
0.1 μmol of fluorescein-labeled RNA, 0, 0.1, 1, or 10 μmol of oligonu-
cleotide, and assay buffer (100mM KCl, 50 mM Tris-HCl, pH 7.4). The
mixtures were heated at 65 °C for 3min and cooled to room tempera-
ture. To separate duplexes from single stranded nucleic acids, each
annealing reaction was run on an 8% non-denaturing polyacrylamide
gel at room temperature. The RNA-DNA duplexes and single-stranded
RNAs were visualized on a UV trans-illuminator.
To identify DNA oligonucleotides that could efficiently compete
with xpt RNA (1–91) for pairing with 5′T-7 in the presence of guanine,
we purchased 5 oligonucleotides (3′T-2 through 3′T-6) predicted to
have a range of melting temperatures when annealed to 5′T-7 and
performed strand-exchange reactions. After preparing 10 pmol of the
xpt RNA (1–91)/5′T-7 duplex as described above, 20 pmol of competing
oligonucleotide in assay buffer, and 0, 20, or 40 pmol of guanine in
assay buffer were added to a total volume of 15 μL. The reaction pro-
ducts were separated and visualized as describe above for the annealing
reaction. A successful strand-exchange reaction resulted in the release
of single-stranded xpt RNA (1–91) from the xpt RNA (1–91)/5′T-7 du-
plex. After testing a variety of reaction temperatures and incubation
times, we found that incubating the reaction overnight (∼18 h) at 4 °C
gave the best signal-to-background ratio.
Fig. 1. (A) In vivo regulation of gene expression by
the xpt-pbuX guanine riboswitch. The diagram re-
presents nucleotides 1–161 of the xpt-pbuX mRNA.
Upon binding to guanine, a conformational change
disrupts the antiterminator and a premature termi-
nator forms when nucleotides 121–134 pair with
nucleotides 142–155. P1, P2, and P3 are base-paired
regions in the guanine-bound form of the riboswitch.
J1-2, J2-3, and J3-1 are joining regions. The dotted
line indicates that the mRNA continues in the 5’ to 3’
direction. (B) Diagram showing how the riboswitch
was adapted for use as a guanine sensor in vitro. RNA
corresponding to nucleotides 1–91 of the xpt-pbuX
mRNA was synthesized by in vitro transcription. 5’T-
1 and 3’T-1 are synthetic DNA oligonucleotides with
sequences corresponding to nucleotides 121–134 and
142–155, respectively, in the natural riboswitch. The
riboswitch RNA was labeled at its 3’ end with
fluorescein. 5’T-1 was labeled at its 5’ end with a
quencher. Binding of guanine would produce an in-
crease in the fluorescence intensity (indicated by
fluorescein changing from filled to open circle) if the
quencher moves away from the fluorescein. (The
sequences of 5’T-1 and 3’T-1 had to be changed to
produce a functional sensor).
Fig. 2. 5’T-1 does not form a stable duplex with xpt RNA (1–91). (A) Figure illustrating
base-pairing between xpt RNA (1–91) and the DNA oligonucleotides 5’T-1 (top) or 5’T-2
(bottom). 5’T-1 corresponds to nucleotides 121-134 of the guanine riboswitch. It was
expected to form an imperfect 12 bp duplex with xpt RNA (1–91). 5’T-2 was a positive
control that formed a perfect 15 bp duplex with xpt RNA (1–91). Solid lines represent
Watson-Crick base pairs. Dots represent non-Watson-Crick base pairs. (B) Electrophoretic
mobility shift assay (EMSA) of duplex formation. The positions of xpt RNA (1–91) and the
duplex formed with 5’T-2 are indicated on the left side of the non-denaturing gel. Under
our assay conditions, 5'T-1 did not form a stable duplex with xpt RNA (1–91) even when
present at a 100-fold molar excess. 5’T-2 formed a stable duplex with xpt RNA (1–91)
when present at a 10-fold molar excess. [Duplex formation went to completion with a 1:1
molar ratio of xpt RNA (1–91) and 5’T-2; not shown].
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2.5. Fluorescence quenching assay
The following ligands were purchased from Sigma: guanine, ade-
nine, hypoxanthine, guanosine, 2′-deoxyguanosine, 3′-deoxyadenosine,
2′-guanosine monophosphate (2′-GMP), 3’-guanosine monophosphate
(3′-GMP), 3′,5′-cyclic diguanylate (c-diGMP), 3′,5′-cyclic diadenylate
(c-diAMP), and 2′,5′-3′,5′-cyclic guanosine monophosphate-adenosine
monophosphate (c-GAMP). Reactions (70 μL total volume) contained:
25 pmol unlabeled riboswitch RNA; 10 pmol riboswitch RNA labeled at
its 3′ end with fluorescein; 70 pmol 5′T-7 with quencher at its 5′ end;
350 pmol 3′T-3; assay buffer; and a variable concentration of ligand as
indicated in the figures. Reactions with the 2′-deoxyguanosine-guanine
hybrid and the c-diGMP-guanine hybrid riboswitches also included
2mM MgCl2. Prior to adding 3′T-3 and the ligand, 5′T-7 was annealed
to the riboswitch RNA by heating at 65 °C for 3min in assay buffer and
cooling to room temperature. The annealing reaction and a mix con-
taining 3′T-3, ligand, and assay buffer (including MgCl2 when needed)
were placed on ice. After 5min on ice, the mix was added to the an-
nealing reaction and incubated at 4 °C for ∼18 h. After incubation, the
fluorescence intensity was measured at 4 °C using assay buffer as the
blank. A one-tailed T-test assuming equal variance was used to de-
termine if signals were greater than background.
2.6. Preparation of initial partially randomized RNA pool for selection
An oligonucleotide pool containing a large number of variants of the
guanine riboswitch was synthesized by IDT (see oligonucleotide DM024
in Section 2.2). Each of the lower case bases shown in the DM024 se-
quence was 27% randomized. For example, consider a randomized
position that is shown as an A in DM024. Of the oligonucleotides in the
Fig. 3. Identifying DNA oligonucleotides that function efficiently
in the strand-exchange reaction. (A) Oligonucleotides tested for
their ability to form a stable duplex with xpt RNA (1–91). The
sequence of 5’T-1 is the same as the 5’ half of the terminator in the
ligand-bound form of the guanine riboswitch. Bases that are not
complementary to xpt RNA (1–91) are in lower case. Asterisks
indicate oligos that could form a stable duplex with xpt RNA
(1–91) when present in stoichiometric amounts. 5’T-7 (indicated
by **) was chosen for use in the strand-exchange reaction. (B)
Oligonucleotides tested for their ability to compete with xpt RNA
(1–91) for pairing with 5’T-7. The sequence of 3’T-1 is the same as
the 3’ half of the terminator in the ligand-bound form of the
guanine riboswitch. Bases that are not complementary to 5’T-7
are in lower case. 3’T-3 (indicated by **) was chosen for use in the
strand-exchange reaction. (C) Strand-exchange reaction. The po-
sitions of fluorescein-labeled xpt RNA (1–91) (lane 1) and the
duplex formed with 5’T-7 are indicated on the left side of the non-
denaturing gel. When strand-exchange occurred, the duplex was converted into free xpt RNA (1–91). Very little strand-exchange occurred in the absence of guanine and 3’T (lanes 2) or in
the presence of 3’T alone (lane 3). Strand-exchange occurred in the presence of 3’T plus 20 pmol of guanine (lane 4) and neared completion in the presence of 3’T and 40 pmol of guanine
(lane 5).
Fig. 4. The fluorescence quenching assay for guanine. (A) Assay design. 5’T-7 and 3’T-3 are DNA oligonucleotides chosen for the assay after screening a number of oligo pairs. When
guanine binds to xpt RNA (1–91), 5’T-7 dissociates form the RNA and pairs with 3’T-3 producing an increase in fluorescence intensity as the quencher moves away from the fluorophore.
(B) Fluorescence intensity as a function of guanine concentration. The sensor was saturated at∼3 μM guanine. (C) Enlargement of the boxed region of the graph in (B) showing that the
sensor can reproducibly detect as little as 5 nM guanine. Fluorescence values are the averages of 4 independent reactions. Error bars are standard deviations. The asterisk indicates that
the signal at 5 nM guanine is significantly higher than background (P= 3 x 10−4). (D) The guanine sensor retains the ligand specificity of the natural guanine riboswitch. The signal
produced by 5 μM guanine was compared to that produced by 5 μM and 50 μM guanosine, adenine, or hypoxanthine. Asterisks indicate signals that were significantly greater than
background (P < 0.05).
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randomized pool, 73% have an A, 9% have a G, 9% have a C, and 9%
have a T at this position. The transcription template was made by
amplifying the randomized oligonucleotide pool using DM025 and
DM026 as primers. A total of 40 pmol (∼2×1013 molecules) of the
randomized oligonucleotide pool was amplified in 30 independent re-
actions (50 μL each). The randomized RNA pool was synthesized, la-
beled, purified, and quantified as described above.
2.7. In vitro selection procedure
The selection strategy is illustrated in Fig. 9A. 200 pmol of bioti-
nylated 5′T-7 was attached to 2mg of streptavidin-coated magnetic
beads (Dynabeads M-270 streptavidin from Invitrogen) according to
manufacturer’s instructions. The beads were captured with a magnetic
stand (Promega) and the liquid was removed. 180 pmol of fluorescein-
labeled randomized RNA in 200 μL of hybridization buffer (50mM Tris
pH 7.4, 500mM NaCl) was added to the beads and the mixture was
rotated overnight at 25 °C to allow the RNA to anneal to immobilized
5′T-7. After RNA binding, unbound RNA was removed as follows: beads
were rinsed 4 times quickly at 25 °C, twice for 30min at 25 °C, and once
for 30min at 4 °C with 400 μL of assay buffer. The mixture was con-
tinuously rotated during each 30min incubation. Beads were captured
between each rinse and the liquid was discarded. Bound RNA was
eluted for various times by rotating at 4 °C in 200 μL assay buffer
Fig. 5. Predicted secondary structures of the guanine, 2’-deoxyguanosine, and hybrid riboswitches. The solid box indicates the P1 stem and flanking nucleotides 1–13 and 82–91 (dotted
lines) of the guanine riboswitch. The dotted box indicates the ligand-binding domain of the 2’-deoxyguanosine riboswitch. The structures of guanine and 2’-deoxyguanosine are shown.
Fig. 6. Sensitivity and specificity of the 2’-deoxyguanosine hybrid sensor. (A) Fluorescence intensity as a function of 2’-deoxyguanosine concentration. The sensor was saturated at∼1 μM
2’-deoxyguanosine. (B) Enlargement of the boxed region of the graph in (A) showing that the sensor can reproducibly detect as little as 15 nM 2’-deoxyguanosine. Fluorescence values are
the averages of 3 independent reactions. Error bars are standard deviations. The asterisk indicates that the signal at 15 nM 2’-deoxyguanosine is significantly higher than background
(P= 0.005). (C) The sensor retains the specificity of the natural 2’-deoxyguanosine riboswitch. The signal produced by 1 μM 2’-deoxyguanosine was compared to that produced by 1 μM
and 50 μM guanosine, 1 μM and 50 μM 2’-deoxyadenosine, or 1 μM and 5 μM guanine. Fluorescence values are the averages of 3 independent reactions. Error bars are standard deviations.
Asterisks indicate signals that were significantly higher than background (P < 0.05).
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containing 5 μM guanine and the eluted RNA was collected. RNA that
remained bound to the beads was removed by heating 3 times in 600 μL
of hybridization buffer for 3min at 55 °C. The RNA removed by each
round of heating was collected in a single tube. The amount of RNA that
eluted with ligand and the amount of RNA removed from the beads by
heating was determined by measuring the fluorescence intensity of a
small aliquot of each of the two fractions. The amount of RNA that
bound to the 5′T-7 beads was calculated as the amount of RNA eluted
with ligand plus the amount of RNA removed by heating. The elution
efficiency was calculated as the percentage of bound RNA eluted with
ligand. The level of background elution was determined in control ex-
periments in which the RNA was eluted with assay buffer. We found
that the highest signal-to-background ratio was achieved when the RNA
was eluted for 6 h. The eluted RNA was precipitated and dissolved in
19.2 μL of water. The RNA was amplified by reverse transcription and
PCR followed by transcription. Reverse transcription reactions con-
tained: 19.2 μL RNA; 2 μL DM026 (50 pmol); 1.6 μL 10mM dNTP;
6.4 μL 5× buffer (supplied with enzyme); 1.6 μL 100mM DTT; and
1.2 μL (300 U) MLV reverse transcriptase (Invitrogen). The reactions
were incubated for 1 h at 42 °C. PCRs contained: 32 μL cDNA (from
reverse transcription); 16 μL (400 pmol) DM025; 16 μL (400 pmol)
DM026; and 288 μL PCR supermix. Each reaction was divided into 6
equal aliquots and cycling was performed as described above. The PCR
products were pooled, diluted to 400 μL with water, extracted once
with phenol-chloroform-isoamyl alcohol (25:24:1 v/v), and pre-
cipitated. All of the PCR product was used for in vitro transcription.
Transcription, labeling, and gel-purification were performed as de-
scribed in the section above called “Synthesis, labeling, purification,
and quantification of RNA”. The selection process was repeated until
the percentage of bound RNA eluted with guanine reached a maximum.
2.8. Cloning and sequencing of cDNAs
PCR products made from selected RNA was cloned using a TA
cloning kit (Invitrogen) according to the manufacturer’s instructions.
Inserts were sequenced using the M13 reverse primer. Sequencing was
performed by Eurofins Genomics. Sequence alignments were performed
with Megalign which is part of the Lasergene software package from
DNAStar.
3. Results
3.1. Adapting a guanine riboswitch for use as a guanine sensor in vitro
In vivo, guanine binding stabilizes a conformation of the guanine
riboswitch that includes a premature transcriptional terminator
(Fig. 1A). We attempted to convert the xpt-pbuX guanine riboswitch
(Mandal et al., 2003) into a sensor by using 3 fragments of the
riboswitch as shown in Fig. 1B. We synthesized the first 91 nucleotides
of the riboswitch by in vitro transcription and labeled the RNA at its 3′
end with fluorescein. This fragment, which we called xpt RNA (1–91),
spans the aptamer domain of the riboswitch. The other two fragments
were DNA oligonucleotides, called 5′T-1 and 3′T-1, with sequences that
corresponded to the 5′ and 3′ halves of the terminator stem. In addition
to pairing with 3′T-1 to form an analog of the terminator, 5′T-1 can pair
with the 3′ end of xpt RNA (1–91) to form a duplex that mimics the
antiterminator (compare Fig. 1A and B). The strategy for our in vitro
guanine assay was to label 5′T-1 at its 5′ end with a quencher, anneal it
to fluorescein-labeled xpt RNA (1–91), and incubate the duplex with
guanine and 3′T-1. We anticipated that guanine binding to xpt RNA
(1–91) would stabilize the P1 stem resulting in a strand-exchange re-
action in which 5′T-1 dissociates from xpt RNA (1–91) and anneals to
3′T-1 (Fig. 1B). Thus, we expected to observe an increase in the fluor-
escence intensity as the quencher moved away from the fluorescein.
Recently, Steinert et al. used a similar system to study the kinetics of
this strand-switching reaction (Steinert et al., 2017).
We first used an electrophoretic mobility shift assay (EMSA) to
determine whether we could anneal 5′T-1 to xpt RNA (1–91) to form a
structure analogous to the antiterminator. We chose to exclude mag-
nesium ions from the reaction to prevent Mg2+-catalyzed hydrolysis of
the RNA during the annealing reaction. We found that 5′T-1 and xpt
RNA (1–91) could not form a stable duplex at room temperature even
when 5′T-1 was present in 100-fold molar excess (Fig. 2). As a positive
control we performed the same experiment using an oligo (called 5′T-2)
that could form a 15 base-pair perfect duplex with xpt RNA (1–91). This
annealing reaction went to completion in the presence of a 10-fold or
100-fold molar excess of 5′T-2 (Fig. 2). In fact, the reaction with 5′T-2
went to completion even when added to xpt RNA (1–91) in a 1:1 ratio
(data not shown). Since the desired duplex with 5′T-1 was unstable in
the absence of magnesium ions, we needed to find an oligo that could
form a stable, but not too stable, duplex with xpt RNA (1–91) under our
chosen conditions. We reasoned that if the duplex was too stable, it
would not efficiently undergo the desired strand-exchange reaction.
Therefore, we used the EMSA to test a variety of oligos for their ability
to anneal to xpt RNA (1–91). We identified 5 oligos that formed a stable
duplex at room temperature in the absence of magnesium ions when
mixed with xpt RNA (1–91) at a 1:1 M ratio (Fig. 3A). We chose oli-
gonucleotide 5′T-7 for further study because it formed the duplex with
the lowest predicted melting temperature.
The sequences of 5′T-1 and 3′T-1 were the same as that found in the
natural guanine riboswitch. Since we could not use 5′T-1, we reasoned
that we would have to find an alternative to 3′T-1. We used the EMSA to
find oligonucleotides that could efficiently compete with xpt RNA
(1–91) for pairing with 5′T-7 in the presence, but not in the absence, of
guanine. Fig. 3B shows the sequences of the oligos tested. 3′T-3 was the
oligo that worked best in this strand-exchange assay. We looked for
Fig. 7. Predicted secondary structures of the c-
diGMP riboswitch and the hybrid riboswitch. The
solid box indicates the region of the c-diGMP ri-
boswitch that was replaced with a truncated version
of the P1 stem from the guanine riboswitch (dotted
box). The top two base pairs of P1 were deleted in
order to obtain the desired predicted secondary
structure. The structure of c-diGMP is shown.
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conditions that gave the highest “signal-to-background” ratio. That is,
we wanted to minimize the amount of strand-exchange that occurred in
the absence of guanine (the “background”) and maximize the amount of
strand-exchange that occurred in the presence of guanine (the “signal”).
We found the optimal reaction conditions to be as follows: 1:2:10 ratio
of xpt RNA (1–91) to 5′T-7 to 3′T-3 in 50mM Tris pH 7.4 and100mM
KCl incubated overnight (∼18 h) at 4 °C (Fig. 3C). Under these condi-
tions, there was very little background (Fig. 3C, Lane 3) and, in the
presence of a 4:1 ratio of guanine to xpt RNA (1–91), the strand-ex-
change reaction went nearly to completion (Fig. 3C, Lane 5). Im-
portantly, inclusion of 2mM MgCl2 significantly decreased the signal-
to-background ratio due to an increase in the background (data not
shown).
Next, we performed the fluorescence-quenching assay. Fig. 4A
shows the desired guanine-triggered strand exchange reaction. As ex-
pected, the fluorescence intensity increased with guanine concentration
and reached a maximum at about 1 μM guanine (Fig. 4B). The assay was
highly reproducible allowing us to detect as little as 5 nM guanine
(Fig. 4C). To assess the ligand specificity of the assay, we compared the
signal produced by 5 μM guanine to that produced by 5 μM or 50 μM
guanosine, adenine, and hypoxanthine. As expected from previously
reported dissociation constants for these ligands (Mandal et al., 2003;
Gilbert et al., 2009), our sensor could detect guanosine and hypox-
anthine but with reduced sensitivity compared to guanine, and could
not detect 50 μM adenine (Fig. 4D).
3.2. Hybrid sensors for the detection of other ligands
We wanted to extend our approach to other riboswitches. However,
we did not want to have to re-optimize the sequences of the DNA oli-
gonucleotides and the assay conditions for each new sensor. Therefore,
we asked whether we could use hybrid riboswitches composed of the P1
stem from the guanine riboswitch (and some flanking single-stranded
RNA) and the ligand-binding domain of a different riboswitch. If so, we
could produce sensors for a variety of ligands that allowed us to use the
same oligonucleotides (5′T-7 and 3′T-3) and the same conditions as
used for the guanine assay.
We attached the ligand-binding domain of a 2′-deoxyguanosine ri-
boswitch from M. florum (Kim et al., 2007) to the P1 stem of the gua-
nine riboswitch and performed fluorescence quenching assays. The
design of the sensor is shown in Fig. 5. The results of the assays are
shown in Fig. 6. We used the program M-fold (http://unafold.rna.
albany.edu/?q=mfold/RNA-Folding-Form) to verify that our hybrid
construct was likely to adopt the desired secondary structure in the
absence of 5′T-7. We were able to use the same assay conditions as used
in the guanine assay except we found that this reaction required the
presence of magnesium ions. (MgCl2 was added after annealing 5′T-7 to
the hybrid sensor to avoid Mg2+-catalyzed RNA hydrolysis at high
temperature.) The signal with the hybrid sensor reached a maximum at
about 1 μM 2′-deoxyguanosine (Fig. 6A). Although inclusion of 2mM
Mg2+ increased the background, the hybrid sensor was able to re-
producibly detect as little as 15 nM 2′-deoxyguanosine (Fig. 6B). The
sensor retained the same ligand specificity as the naturally-occurring 2′-
deoxyguanosine riboswitch (Kim et al., 2007). In addition to 2′-deox-
yguanosine, the sensor could detect guanosine and guanine but with
much lower sensitivity (Fig. 6C). The sensor could not detect 50 μM 2′-
deoxyadenosine.
Next, we attached the ligand-binding domain of a 3′,5′-cyclic-di-
guanylate (c-diGMP) type I riboswitch from V. cholerae (Sudarsan et al.,
2008) to a truncated version of the P1 stem of the guanine riboswitch.
We found that we had to remove two base-pairs from near the top of the
P1 stem in order for the hybrid sensor to fold into the proper secondary
structure as predicted by the program M-fold. The design of the hybrid
sensor is shown in Fig. 7. The results of the fluorescence-quenching
assays are shown in Fig. 8. As with the 2′-deoxyguanosine sensor, the c-
diGMP sensor worked only in the presence of magnesium ions. The
maximum signal was obtained with ∼3 μM c-diGMP (Fig. 8A) and we
could reproducibly detect as little as 3 nM c-diGMP (Fig. 8B). Fig. 8C
Fig. 8. Sensitivity and specificity of the 3’,5’-c-diGMP hybrid sensor. (A) Fluorescence intensity as a function of c-diGMP concentration. The sensor was saturated at∼3 μM c-diGMP. (B)
Enlargement of the boxed region of the graph in (A) showing that the sensor can reproducibly detect as little as 3 nM c-diGMP. Fluorescence values are the averages of 3 independent
reactions. Error bars are standard deviations. The asterisk indicates that the signal at 3 nM c-diGMP is significantly higher than background (P= 0.005). (C) The sensor retains the
specificity of the natural c-diGMP riboswitch. The signal produced by 5 μM 3,5’-c-diGMP was compared to that produced by 5 μM and 50 μM 3’,5’-c-diAMP; 2’,5’-3’,5’-c-GAMP; 2’-GMP; or
3’-GMP. Fluorescence values are the averages of 3 independent reactions. Error bars are standard deviations. Asterisks indicate signals that are significantly higher than background
(P < 0.05).
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shows that the sensor is highly specific for c-diGMP. It could not detect
50 μM 3′,5′-c-diAMP, 2′-GMP, or 3′-GMP. The signal produced by c-
GAMP (2′,5′-3′,5′-cyclic guanosine monophosphate-adenosine mono-
phosphate) at 1 μM was barely above background. Surprisingly, the
signal did not increase with 50 μM c-GAMP. One possible explanation is
that c-GAMP binds readily to the sensor but only poorly induces the
strand-exchange reaction.
3.3. Strategy for the selection of sensors with novel ligand specificity: proof-
of-principle
To further extend the utility of our approach, we devised an in vitro
selection scheme to produce sensors with novel ligand specificity. The
idea is to partially randomize the sequence of an existing sensor and
select variants capable of detecting ligands that are structurally-related
to the original ligand. The selection strategy is illustrated in Fig. 9A for
a partially-randomized version of our guanine sensor. The partially-
randomized pool will contain RNAs with a wide variety of sequences
but each RNA will be related to the guanine sensor. The hypothesis is
that some of the variants will have altered ligand specificity. The system
is identical to the fluorescence quenching assay except biotin, rather
than a quencher, is placed at the 5′ end of 5′T-7, and the biotinylated
oligos are attached to streptavidin-coated magnetic beads. The RNAs in
the initial RNA pool are labeled with fluorescein and immobilized on
the beads by annealing to 5′T-7. After washing to remove unbound
RNA, the beads are incubated with the desired ligand and RNAs that
elute from the beads are collected. The eluted RNAs are amplified by
reverse transcription-polymerase chain reaction (RT-PCR) and the re-
sulting cDNAs are used as templates to transcribe a new RNA pool. In
the early rounds of selection, most of the eluted RNA represents back-
ground due to random dissociation from 5′T-7. Subsequent rounds of
selection enrich the pool for RNAs that elute efficiently only when
bound to the ligand. The selection is continued until the amount of RNA
that elutes from the beads reaches a maximum. Finally, cDNAs derived
from the eluted RNA are sequenced to identify the selected RNAs.
We first asked whether we could anneal the guanine sensor to 5′T-7
when 5′T-7 was bound to magnetic beads, and whether the sensor
would elute from the beads in the presence of guanine and 3′T-3. We
Fig. 9. (A) In vitro selection strategy for selecting ri-
boswitch variants with novel ligand specificity. The
system is identical to the quenching assay shown in
Fig. 1B except the quencher on 5’T-7 was replaced
with a magnetic bead via a biotin-streptavidin inter-
action, and the sequence of the ligand- binding do-
main (dotted line) was partially randomized. 3’T-3 is
not shown because it was not included in the selec-
tion experiment discussed in the text. (B) Alignment
of the xpt RNA (1–91) cDNA with cDNA sequences
selected with guanine. Bases that differ from those
found in xpt RNA (1–91) are highlighted in black. “N”
represents a base that could not be called by the se-
quencing software which was assumed to be a “T”.
Nucleotides 21-75 were partially randomized. (C)
Assay of selected RNA function. Using the fluores-
cence quenching assay, the ability of selected RNAs
S6, S8, S11, or S3 to detect 100 nM guanine was
compared to that of xpt RNA (1–81). The y-axis (Net
Fluorescence Intensity) is the difference between the
fluorescence intensity produced in the presence of
100 nM guanine minus the background fluorescence
produced in the absence of ligand. Values are the
averages of 3 independent reactions. Error bars are
standard deviations. Unlike S6, S8, and S11 RNAs,
the fluorescence intensity produced by S3 RNA was
not significantly higher than background.
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added 180 pmol of heat-denatured xpt RNA (1–91) to magnetic beads
with 200 pmol of bound 5′T-7. We found that the annealing reaction
was very slow. After incubating overnight, only about 30 pmol of RNA
was bound to the beads. Longer incubation times did not result in more
RNA binding. This result suggested that a large fraction of 5′T-7 on the
beads was inaccessible to the RNA. We then measured the amount of
RNA eluted from the beads after incubation for various lengths of time
with 5 μM guanine and 150 pmol of 3′T-3 under the same conditions as
used for the quenching assay. We measured the level of background
elution by incubating the beads under identical conditions but in the
absence of guanine. We found that the highest signal-to-background
ratio was achieved with an incubation time of 6 h.
Interestingly, we found that the signal-to-background ratio in-
creased when the experiment was performed without 3′T-3. This was
due to the fact that the amount of RNA eluted with buffer (background)
decreased more than the amount of RNA eluted with guanine (signal).
3′T-3 had the opposite effect on the fluorescence quenching assay (data
not shown). The role of 3′T-3 is to capture 5′T-7 as it dissociates from
xpt RNA (1–91), thus driving the strand exchange reaction in the for-
ward direction. However, since the RNA binds very slowly when 5′T-7
is on the beads, it appeared that 3′T-3 was not required to prevent the
eluted RNA from re-attaching to the beads during the 6 h incubation.
Under the optimal conditions, about 7.5 pmol (25%) of the bound xpt
RNA (1–91) eluted with 5 μM guanine. Only about 0.8 pmol (∼2.5%) of
RNA eluted when the beads were incubated with assay buffer only,
giving a ∼10:1 signal-to-background ratio.
To test our selection scheme, we performed a proof-of-principle
experiment. To produce the initial RNA pool, we partially randomized
the sequence of our guanine sensor and bound ∼30 pmol (1.8× 1013
molecules) of the RNA to the magnetic beads as described above. We
randomized the sequences of only the joining regions (J1-2, J2-3, and
J3-1) and the base pairs at the bottom of the P1, P2, and P3 stems (see
Fig. 1B). We did not randomize the remainder of the stems or their
single-stranded loops. Since xpt RNA (1–91) was only partially rando-
mized, the initial RNA pool included a significant amount of RNA with
no sequence changes. Thus, we attempted to isolate the original gua-
nine sensor (and, possibly, functional variants) by using guanine as the
ligand during selection. After only 4 rounds of selection, the RNA elu-
tion efficiency increased from background levels (∼2% elution) to
about 20% elution. The elution efficiency did not increase with further
rounds of selection. Since 20% elution is similar to the elution effi-
ciency of pure xpt RNA (1–91) (∼25%), we predicted that our selected
RNA pool consisted primarily of xpt RNA (1–91). We sequenced 16
cDNA clones prepared from the selected RNA and found that the se-
quences of 9 of the clones were identical to that of xpt RNA (1–91)
(Fig. 9B). Three of the sequences differed from xpt RNA (1–91) at only 1
or 2 positions (clones S6, S8, and S11 in Fig. 9B). Clone S6 had two
sequence changes that converted the A25-U45 pair at the base of stem
P2 to a G-C pair. It is known that the structure of the P2 stem is an
important determinant of ligand affinity and specificity (Edwards and
Batey, 2009). Clone S8 had a single base change that disrupted the G27-
C43 pair near the middle of P2 by changing the G27 pair to a U. Since
this base was not changed in the original randomized RNA pool, it
probably arose during the selection due to an error made by reverse
transcriptase or Taq DNA polymerase. Clone S11 changed U48 in J2-3
to a C. It is known that U48 bulges out of the ligand binding pocket and
does not contact the bound guanine (Serganov et al., 2004), so it is not
surprising that xpt RNA (1–91) could tolerate this change. The other 4
sequences (clones S3, S9, S16, and S17) contained a large number of
changes compared to xpt RNA (1–91) and probably represented RNAs
that eluted randomly from the beads (not shown in Fig. 9B). We tran-
scribed the RNAs encoded by clones S6, S8, and S11 and S3, and tested
each of them for their ability to detect 100 nM guanine in the fluores-
cence quenching assay (Fig. 9C). The fluorescence signals produced by
both S6 and S8 RNA were about half that produced by xpt RNA (1–91).
These results are consistent with the known effects of mutations in the
P2 stem of the guanine riboswitch (Edwards and Batey, 2009). S11 RNA
gave the same signal as xpt RNA (1–91). S3, the RNA with a highly
divergent sequence could not detect 100 nM guanine.
4. Discussion
Although much work has focused on using riboswitches as bio-
sensors in vivo, less effort has been exerted toward using riboswitches to
detect ligands in vitro. One highly successful approach for making
sensors for both in vitro and in vivo detection of ligands has been to fuse
various aptamer domains via a short “communication module” to a
fluorescent aptamer such as “Spinach” (Litke et al., 2016; Paige et al.,
2011; Nakayama et al., 2012; Kellenberger et al., 2013; Bhadra and
Ellington, 2014; Kellenberger et al., 2015; Ketterer et al., 2016; Bose
et al., 2016). The fusions are designed such that ligand binding to the
aptamer domain allows the fluorescent aptamer to fold into its active
conformation. However, this approach often requires fairly extensive
re-design and optimization for each new aptamer domain. Our work
sought to convert riboswitches into highly sensitive and specific sensors
and to devise a system that would facilitate the isolation of sensors with
novel ligand specificities without the need for extensive optimization
for each new sensor. This was accomplished by exploiting the modular
nature of riboswitches and optimizing the stabilities of the ligand-free
and ligand-bound forms of our sensors. We are currently testing whe-
ther this approach can be extended to aptamer domains from ri-
boswitches that detect ligands other than purine derivatives and ri-
boswitches that activate rather than inhibit gene expression upon
ligand binding. As shown by Ceres et al. designing hybrid “ON”
switches poses a particular challenge (Ceres et al., 2013bb).
We realized that our approach would not necessarily work for every
riboswitch and, of course, nature has not designed riboswitches that can
detect every possible ligand of interest. Many groups have attempted to
extend the ligand specificity of sensors by replacing naturally-occurring
aptamer domains with RNA aptamers produced by in vitro selection
using the standard SELEX protocol. This approach has been successful
for some applications but has also failed because ligand binding did not
induce the required conformational change (Robertson and Ellington,
2000). To circumvent this problem, we and others previously devised
an in vitro selection strategy for isolating RNAs that not only bind to the
desired ligand but that are also guaranteed to undergo a desired con-
formational change (Nutiu and Li, 2005; Morse, 2007; Rajendran and
Ellington, 2008; Vandenengel and Morse, 2009). Based on our sensor
design and our previous selection strategy, we devised a scheme for
changing the ligand specificity of naturally-occurring riboswitches.
For our proof-of-principle selection experiment, we partially ran-
domized the ligand-binding domain of the guanine riboswitch and at-
tempted to isolate the original guanine riboswitch using guanine as the
ligand. The success of this experiment showed that our strategy works.
In addition to isolating the original guanine riboswitch, we found three
functional variants, indicating that our selection scheme will also be
useful for structure-function studies. We sequenced only 16 of the RNAs
selected with guanine, but deep sequencing should reveal most, if not
all, of the possible functional variants.
Importantly, each of our hybrid sensors represent a new starting
point for in vitro selection and there will be no need to extensively
optimize the conditions for each new selection. Thus, we should be able
to find sensors for ligands related to the cognate ligand of each ri-
boswitch, and we will be able to perform studies that probe the se-
quence and structure requirements for each new ligand-binding do-
main.
It is instructive to compare our selection scheme to recently re-
ported experiments. Koizumi et al. completely randomized the aptamer
domain of a self-cleaving allosteric hammerhead ribozyme and selected
novel aptazymes that could detect cGMP, cAMP, and cCMP (Koizumi
et al., 1999). Schemes for selecting functional self-cleaving ribozymes
have an intrinsic advantage over selecting riboswitches. Functional
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ribozymes can be cleanly separated from non-functional variants by
isolating cleavage fragments. (Koizumi et al. used electrophoresis to do
this.) Thus, there is very little background to overcome during the se-
lection. In our strategy for selecting riboswitches, we collect RNAs that
dissociate from immobilized 5′T-7 upon ligand binding, but about 2%
of this RNA dissociates randomly, independent of ligand binding. Thus,
we see no increase in the amount of eluted RNA until functional RNAs
comprise greater than 2% of the selected population. With this rela-
tively high background, it is more likely that rare functional variants
will be lost if many rounds of selection are required to purify the de-
sired RNAs. However, deep sequencing of the selected RNAs should
obviate this problem since functional variants could be identified as
having been enriched after only a few rounds of selection. Additionally,
we could reduce (but not eliminate) background by reversing our
strategy and capturing functional RNAs through annealing the RNA to
immobilized 3′T-3. In this strategy, 5′T-7 would be covalently linked to
the aptamer domain of a riboswitch through an RNA linker. A similar
approach was reported recently for the selection of TPP sensors
(Martini et al., 2015). Another source of our relatively high background
is that a significant fraction of the immobilized 5′T-7 is inaccessible or
sterically hindered resulting in very slow annealing of RNAs. Thus,
elution of RNAs from the beads is essentially irreversible during our 6 h
elution reaction. A possible solution to this problem is to use a longer
linker between 5′T-7 and biotin on its 5′ end or reduce the density of
5′T-7 on the beads. Randomly eluted RNAs should more readily re-
anneal to the more accessible 5′T-7, while ligand-bound RNAs should
re-anneal slowly. This approach may result in the need to include 3′T-3
in the selection to further decrease the rate at which functional RNAs
re-anneal to 5′T-7.
In another recent paper, Porter et al. used the standard SELEX
procedure to find variants of the aptamer domain of the xpt-guanine
riboswitch that could bind to 5-hydroxytryptophan and 3,4-dihydrox-
yphenylalanine (Porter et al., 2017). The selected variants were con-
verted into robust sensors for their ligands by fusing them to a Broccoli
aptamer via a communication module. Our selection strategy inverts
the standard SELEX procedure. Rather than selecting RNAs that bind to
an immobilized ligand, we anneal the randomized RNA pool via base-
pairing to an immobilized oligo and select RNAs that elute upon
binding to the ligand. The selected RNAs can then be directly used as in
vitro sensors via our quenching assay. Thus, the additional step of fusing
the selected RNAs to a fluorescent aptamer will not be required.
We are interested in finding variants of our guanine sensor that can
detect hypoxanthine but not guanine. Hypoxanthine is identical to
guanine except for the absence of the extracyclic amino group found in
guanine. A hypoxanthine sensor that cannot bind to guanine would
have to prevent guanine binding through a steric clash with the extra
amino group, but still make productive contacts with other regions of
the base. This would be a challenge to achieve through rational design
as it would likely require multiple base changes.
5. Conclusion
Riboswitches are being applied as analytical tools in biochemistry,
genetics, cell biology, medicine, environmental science, forensics, and
many other areas (Lee et al., 2016; Machtel et al., 2016). In the exciting
new field of synthetic biology, riboswitches have become the preferred
tool for constructing new gene regulatory devises and genetic circuits
(Groher and Suess, 2014; Jo and Shin, 2009; Topp et al., 2010; Weber
and Fussenegger, 2011; Chappell et al., 2015). Our work will contribute
to increasing the availability of riboswitches with novel ligand speci-
ficity.
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